TOPICAL IMMUNOTHERAPY IN ALOPECIA AREATA
Authors:
- Rudolf HappleRHRudolf Happle
- 1 October 1996
- journal article
- Published by Elsevier in Dermatologic Clinics
- Vol. 14 (4) , 739-744
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Does lnterleukin-1 Induce Hair Loss?Dermatology, 1995
- Cytokine mRNA Levels in Alopecia Areata Before and After Treatment with the Contact Allergen DiphenylcyclopropenoneJournal of Investigative Dermatology, 1994
- Topical Immunotherapy for Alopecia areata: Re-Evaluation of 139 Cases after an Additional Follow-Up Period of 19 MonthsDermatology, 1992
- Aberrant Intercellular Adhesion Molecule-1 (ICAM-1) Expression by Hair-Follicle Epithelial Cells and Endothelial Leukocyte Adhesion Molecule-1 (ELAM-1) by Vascular Cells Are Important Adhesion-Molecule Alterations in Alopecia AreataJournal of Investigative Dermatology, 1991
- Treatment of alopecia areata with diphenylcyclopropenoneJournal of the American Academy of Dermatology, 1991
- Persistent vitiligo induced by diphencyproneBritish Journal of Dermatology, 1990
- Erythema multiforme-Like Eruptions: a Rare Side Effect of Topical Immunotherapy with DiphenylcyclopropenoneDermatology, 1990
- In situ lymphocyte subsets in alopecia areata before and during treatment with a contact allergenClinical and Experimental Dermatology, 1987
- Abnormal Expression of Class I and Class II Major Histocompatibility Antigens in Alopecia Areata: Modulation by Topical Immunotherapy*Journal of Investigative Dermatology, 1987
- Therapies versus placebo in the treatment of patchy alopecia areataJournal of the American Academy of Dermatology, 1986